EDU 26 - Toxicities, Reconstruction Complications, and Quality-of-Life after Radiotherapy for Breast Cancer: Looking Harder
11:15 AM - 12:30 PM
Location: Room W176
Session Type: Education
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.50 MDCB Credits
This session will focus on toxicity of radiation for breast cancer, with the theme of "looking harder" for the adverse effects of our treatment. It is true that the incidence of many complications is quite low. However, the breast cancer specific mortality improvement from radiotherapy is also a marginal improvement for many women. Hence understanding the risks of treatment and working towards mitigating them is important. There will be 3 speakers, each speaking for 15-17 minutes with a moderator and time for questions after each presentation. Late toxicities will include impact on reconstructive outcomes, lymphedema, cardiotoxicity, and second malignancy. The importance of quality-of-life and patient reported outcome tools will be discussed.
- Understand and describe the relative incidence of toxicities such as pneumonitis, cardiotoxicity, lymphedema, second malignancy, shoulder stiffness, and esophagitis with breast radiotherapy/regional nodal irradiation.
- Understand and describe best available literature on outcomes of PMRT on reconstructions, with a discussion on immediate vs delayed and implant vs autologous.
- Understand and interpret QOL endpoints in clinical trials and possible utility of these tools in practice improvement.
11:15 AM - 11:35 AM
Understanding the incremental risk of toxicities after breast radiotherapy
Speaker: – Memorial Sloan Kettering Cancer Center
11:35 AM - 11:55 AM
Post-mastectomy RT and other Risk Factors for Reconstruction Complications
Speaker: – University of Utah Huntsman Cancer Institute
11:55 AM - 12:15 PM
Patient Reported Outcomes and Quality of Life tools in clinical trials and in practice
Speaker: – University of California, Los Angeles